You are here

IPOs

The Ides of March bring no misfortune to biotech, as industry logs second-busiest IPO week of 2021

Endpoints

Fri, 03/19/21 - 11:22 am

Connect Biopharma

Finch Therapeutics

Gain Therapeutics

Oxford vaccines spinout Vaccitech raises $168M, laying groundwork for an IPO

MedCity News

Thu, 03/18/21 - 10:52 am

University of Oxford

Rubius launches $200m IPO to fund red blood cell therapies

Pharmaforum

Wed, 03/17/21 - 10:40 am

Rubius Therapeutics

Prometheus upsizes IPO by 33% ahead of pricing

Endpoints

Thu, 03/11/21 - 11:43 pm

Prometheus Biosciences

Are SPACs Better Than Traditional IPOs?

BioSpace

Wed, 03/10/21 - 10:47 pm

Biotech IPO market looks to ramp back up as BMS partner Ikena and its immunometabolism therapies eye public offering

Endpoints

Mon, 03/8/21 - 09:15 pm

Kyn Therapeutics

Four IPOs and a SPAC pitch a new slate of microbiome, cancer and inflammatory drugs to Wall Street

Endpoints

Mon, 03/1/21 - 11:42 pm

Finch Therapeutics

Connect Biopharma

Transcode Therapeutics

With Novavax vaccine deal under its belt, SK Bioscience plots out March IPO on the Korean exchange

Endpoints

Wed, 02/24/21 - 11:21 am

After a slow week, the IPO train is back up and running as 3 more biotechs hop aboard

Endpoints

Mon, 02/22/21 - 11:45 pm

Prometheus Biosciences

Longboard Pharmaceuticals

Gain Therapeutics

A pair of biotechs prepares to hit Nasdaq, as total 2021 IPO raise quickly approaches $3B

Endpoints

Sat, 02/13/21 - 11:10 pm

Decibel Therapeutics

Biotech flotations offer venture funds an accelerating exit

EP Vantage

Thu, 02/11/21 - 10:39 am

Nautilus set to go public in reverse merger with Perceptive SPAC, aims to test proteomics platform with big-name backers

Endpoints

Tue, 02/9/21 - 11:21 am

Nautilus Biotechnology

Life Sciences Companies Ringing the Nasdaq Bell this Week

BioSpace

Thu, 02/4/21 - 08:10 pm

Sana Biotechnology

Sensei Biotherapeutics

Landos Biopharma

Aspira Women's Health

Cell therapy biotech Sana Biotechnology prices further upsized IPO at $25, above the upwardly revised range

Renaissance Capital

Thu, 02/4/21 - 10:38 am

Sana Biotechnology

Immunocore IPO filing reveals kickback scheme, Immatics row and phishing attacks

Fierce Biotech

Tue, 01/26/21 - 11:32 am

IPO tracker: 2021 gets started with a flurry of new offerings

Endpoints

Mon, 01/25/21 - 10:43 am

Sana Biotechnology

Sensei Biotherapeutics

Bolt Biotherapeutics

Terns Pharmaceuticals

Gracell Biotechnologies

Cullinan Oncology

After bagging Yescarta exec as CMO, T-cell biotech NexImmune files for $86M IPO

Fierce Biotech

Thu, 01/21/21 - 10:32 am

Gilead Sciences

Sana Bio's $150 Million IPO Expected to Provide Market Valuation of $10 Billion

BioSpace

Tue, 01/19/21 - 10:53 am

Sana Biotechnology

Astounding success greets newly public device makers

EP Vantage

Mon, 01/18/21 - 12:59 pm

Genetron Holdings

Burning Rock Biotech

Will Murky Trial Data Undercut Landos' $100 Million IPO Launch?

BioSpace

Thu, 01/14/21 - 10:30 pm

Landos Biopharma

Pages